Enanta Pharmaceuticals, Inc. - Common Stock (NQ:ENTA)

12.73 +0.60 (+4.95%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Price and Volume

Volume	273,607
Open	12.08
Bid (Size)	11.80 (100)
Ask (Size)	13.00 (300)
Prev. Close	12.13
Today's Range	11.89 - 13.00
52wk Range	4.090 - 15.34
Shares Outstanding	21,055,392
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Reports Mixed Q4 and Full-Year 2025 Results ↗

November 17, 2025

Enanta Pharmaceuticals reported mixed Q4 2025 results, missing revenue but beating EPS estimates. The biotech firm highlighted strong progress in its RSV and immunology drug pipeline.

Via Chartmill

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2025

November 17, 2025

From Enanta Pharmaceuticals, Inc.

Via Business Wire

Performance

YTD	+127.7%	+127.7%
1 Month	+15.6%	+15.6%
3 Month	+48.2%	+48.2%
6 Month	+121.4%	+121.4%
1 Year	+40.2%	+40.2%

More News

Earnings Scheduled For November 17, 2025 ↗

November 17, 2025

Via Benzinga

Enanta Pharma's Earnings: A Preview ↗

November 14, 2025

Via Benzinga

This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday ↗

November 14, 2025

Via Benzinga

Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences

November 04, 2025

From Enanta Pharmaceuticals, Inc.

Via Business Wire

Enanta Pharmaceuticals Presents New Data for Zelicapavir, its N-Protein Inhibitor, and EDP-323, its L-Protein Inhibitor, Both in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025

October 20, 2025

From Enanta Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 16, 2025

Via Benzinga

Enanta Pharmaceuticals to Present Data for Zelicapavir and EDP-323, Two Candidates in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025

October 07, 2025

From Enanta Pharmaceuticals, Inc.

Via Business Wire

Enanta Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

October 02, 2025

From Enanta Pharmaceuticals, Inc.

Via Business Wire

Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 01, 2025

Via Benzinga

Why Ryvyl Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket ↗

October 01, 2025

Via Benzinga

Enanta Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

September 30, 2025

From Enanta Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 30, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

September 30, 2025

Via Chartmill

Enanta Pharmaceuticals Announces Proposed Public Offering of Common Stock

September 30, 2025

From Enanta Pharmaceuticals, Inc.

Via Business Wire

Let's take a look at the stocks that are in motion in today's session. ↗

September 29, 2025

Via Chartmill

Enanta Pharmaceuticals Stock Rises 58% – Here’s An Important Update ↗

September 29, 2025

Via Stocktwits

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 29, 2025

Via Benzinga

Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults ↗

September 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 29, 2025

Via Benzinga

Top stock movements in today's session. ↗

September 29, 2025

Via Chartmill

Enanta Pharmaceuticals Reports Positive Topline Results from its Phase 2b Study of Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults

September 29, 2025

From Enanta Pharmaceuticals, Inc.

Via Business Wire

Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗

September 29, 2025

Via Benzinga

Frequently Asked Questions

Is Enanta Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Enanta Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Enanta Pharmaceuticals, Inc. - Common Stock trade on?

Enanta Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Enanta Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Enanta Pharmaceuticals, Inc. - Common Stock is ENTA on the Nasdaq Stock Market

What is the current price of Enanta Pharmaceuticals, Inc. - Common Stock?

The current price of Enanta Pharmaceuticals, Inc. - Common Stock is 12.73

When was Enanta Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Enanta Pharmaceuticals, Inc. - Common Stock was at 11/21/25 04:00 PM ET

What is the market capitalization of Enanta Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Enanta Pharmaceuticals, Inc. - Common Stock is 268.04M

How many shares of Enanta Pharmaceuticals, Inc. - Common Stock are outstanding?

Enanta Pharmaceuticals, Inc. - Common Stock has 268M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.